Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Louisville, Kentucky Clinical Trials

A listing of Louisville, Kentucky clinical trials actively recruiting patient volunteers.

RESULTS

Found (554) clinical trials

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

A multi-regional clinical trial with participating sites planned in the following countries pending approval from the applicable oversight authorities: Argentina Brazil Bulgaria Canada Colombia Czech Republic Denmark France Germany Hungary India Israel Japan Mexico Netherlands Poland Romania Russian Federation Slovakia South Africa Spain Ukraine United Kingdom United States

Phase

4.47 miles

Learn More »

This study looks at Bimatoprost Sustained Release (SR) implant compared to Selective Laser Trabeculoplasty in lowering the intraocular pressure of patients with Open-angle Glaucoma or Ocular Hypertension.

Phase N/A

4.47 miles

Learn More »

Phase

4.47 miles

Learn More »

This study examines a new vehicle (1.5% Transdermal System TDS) to deliver the study drug to patients who have a Chalazion (a cyst in the eyelid that is caused by a blocked meibomian gland) compared to placebo (TDE).

Phase

4.47 miles

Learn More »

The Primary Objective if this study is to evaluate the efficacy of SHP640 based on clinical resolution (Defined as absence of bulbar conjunctival injection and ocular conjunctival discharge) compared with placebo in the treatment of subject with Adenoviral Conjunctivitis in the study at Visit 3(Day5).

Phase

4.47 miles

Learn More »

The Primary Objective if this study is to evaluate the efficacy of SHP640 based on clinical resolution (Defined as absence of bulbar conjunctival injection and ocular conjunctival discharge) compared with placebo in the treatment of subject with Bacterial Conjunctivitis in the study at Visit 3(Day5).

Phase

4.47 miles

Learn More »

The objective of this study is to evaluate the efficacy and safety of two strengths of Lacripep™ ophthalmic solution versus placebo administered 3 times a day for 4 weeks with subjects with Dry Eye associated with Primary Sjögren’s Syndrome

Phase

4.47 miles

Learn More »

Sexual Function Trial of Overactive Bladder: Medication Versus PTNS

Specific aims: Primary aim: Aim 1: To determine if there is greater improvement in female sexual function as measured by the female sexual function index (FSFI) with percutaneous tibial nerve stimulation (PTNS) as compared to medical therapy (MT). Hypothesis: We expect that there will be a greater improvement in overall ...

Phase N/A

5.04 miles

Learn More »

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy Surgery and/or Radiation Therapy

This is a randomized double-blind placebo-controlled phase III trial of aspirin (300 mg daily) in early stage node-positive HER2 negative breast cancer patients. Patients will be randomized 1:1 within stratum defined by: Hormone Receptor status (HR positive vs HR negative), body mass index (<30 vs 30 kg/m2) and stage (Stage ...

Phase

5.13 miles

Learn More »

A Study of ASP2215 (Gilteritinib) Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission

Subjects in CR1 will be approached for this study after induction/consolidation therapy is complete and a decision not to proceed with transplantation is made or a suitable donor could not be identified. Subjects will be randomized in a 2:1 ratio to receive gilteritinib or placebo. Subjects will enter the screening ...

Phase

5.13 miles

Learn More »